Literature DB >> 14614854

BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity.

Kan Saito1, Kimberley F Tolias, Abdelhafid Saci, Henry B Koon, Lisa A Humphries, Andrew Scharenberg, David J Rawlings, Jean-Pierre Kinet, Christopher L Carpenter.   

Abstract

Intracellular signaling by most cell surface receptors requires the generation of two major second messengers, phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3) and inositol-1,4,5-trisphosphate (IP3). The enzymes that produce these second messengers, phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC), utilize a common substrate, phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2). Until now, it has not been clear whether de novo PtdIns-4,5-P2 synthesis is necessary for PtdIns-3,4,5-P3 and IP3 production. Here we show that BTK, a member of the Tec family of cytoplasmic protein tyrosine kinases, associates with phosphatidylinositol-4-phosphate 5-kinases (PIP5Ks), the enzymes that synthesize PtdIns-4,5-P2. Upon B cell receptor activation, BTK brings PIP5K to the plasma membrane as a means of generating local PtdIns-4,5-P2 synthesis. This enzyme-enzyme interaction provides a shuttling mechanism that allows BTK to stimulate the production of the substrate required by both its upstream activator, PI3K, and its downstream target, PLC-gamma2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614854     DOI: 10.1016/s1074-7613(03)00297-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  72 in total

1.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

Review 2.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

3.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

Review 4.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  Regulation of the actin cytoskeleton by phosphatidylinositol 4-phosphate 5 kinases.

Authors:  Yuntao S Mao; Helen L Yin
Journal:  Pflugers Arch       Date:  2007-05-23       Impact factor: 3.657

6.  How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.

Authors:  Linglan Fang; Jessica Vilas-Boas; Sujata Chakraborty; Zachary E Potter; Ames C Register; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2020-06-23       Impact factor: 5.100

7.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 8.  Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.

Authors:  Julie A Readinger; Kristen L Mueller; Ana M Venegas; Reiko Horai; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 9.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

10.  Targeting the phosphorylation site of myristoylated alanine-rich C kinase substrate alleviates symptoms in a murine model of steroid-resistant asthma.

Authors:  Chien-Neng Wang; Yu-Chao Lin; Bo-Chun Chang; Ching-Hsien Chen; Reen Wu; Chen-Chen Lee
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.